MET immunochemistry: a reliable screening tool for MET exon 14 skipping mutations in non-small cell lung cancer? | Ann Transl Med;8(22): 1538, 2020 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

MET immunochemistry: a reliable screening tool for MET exon 14 skipping mutations in non-small cell lung cancer?

Pruis, Melinda A; von der Thüsen, Jan H; Dubbink, Hendrikus Jan.

Affiliation

Pruis MA; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
von der Thüsen JH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Ann Transl Med ; 8(22): 1538, 2020 Nov.

Article in En | MEDLINE | ID: mdl-33313283

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Ann Transl Med Year: 2020 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Ann Transl Med Year: 2020 Document type: Article Affiliation country: